Additional benefit of standardized computed tomography-based lymph node assessment utilizing Node-RADS in esophageal adenocarcinoma.

ESMO Gastrointest Oncol · 2026 · PMC13059021 · PMID 41958453

Europe PMC DOI

hedged sentence

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

showed a trendP = 0.058so close (0.05 < p ≤ 0.1)

This effect remained significant in uN+ cases (42.6 versus 57.6 months, χ 2 = 4.581, P = 0.032) and showed a trend in uN− cases (60.8 versus 81.2 months, χ 2 = 3.589, P = 0.058; Figure 2 B and C).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.